Patrick McCall
CFO & SecretaryMr. Patrick McCall, CPA, serves as Chief Financial Officer at IN8bio, Inc. since February 2021 and serves as its Company Secretary. Mr. McCall is experienced in building and leading financial organizations in public and private life sciences companies. He has provided financial insights, business development, corporate development and strategic planning to growth-oriented companies across several industries. Most recently, he was Vice President of Finance at Turnstone Biologics, a global biotechnology company, where he managed strategic and financial operations including financial reporting, international tax, strategic financial planning & analysis, acquisitions, partnerships and supported investor relations. Prior to that, Mr. McCall was the Senior Director of Finance and Corporate Controller for Catalyst Biosciences, a publicly-traded biotechnology company. He was responsible for the overall corporate accounting function and led SEC reporting including the preparation of an SEC S-1 registration statement. Mr. McCall held previous positions of increasing responsibility at Apple, Chubb and began his career as an auditor at the accounting firm Deloitte. Mr. McCall is a certified public accountant. He earned a B.S. in Accounting from Drexel University and an M.B.A. from Cornell University.
Positions
- Company NameIN8bio, Inc.Stock CodeINABPositionCFO & SecretaryColleagues
- THTai-Wei HoCo-Founder, CEO & Director
- JRJeremy R. GraffInterim Independent Chair
- KRKate RochlinPresident & COO
- LSLawrence S. LambExecutive VP, Co-Founder & Chief Scientific Officer
- OPOxana PolyakovaSenior Vice President of Research & Development
- PCPeter C. BrandtIndependent Director
- LGLuba GreenwoodIndependent Director
- EWEmily Wang FairbairnIndependent Director
